|
N4BP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.004090E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.262000E-03 |
| Normal-vs-Stage2 |
2.987400E-01 |
| Normal-vs-Stage3 |
3.852800E-01 |
| Normal-vs-Stage4 |
2.244600E-01 |
| Stage1-vs-Stage2 |
4.898800E-01 |
| Stage1-vs-Stage3 |
3.631800E-01 |
| Stage1-vs-Stage4 |
9.434800E-01 |
| Stage2-vs-Stage3 |
9.202600E-01 |
| Stage2-vs-Stage4 |
6.885600E-01 |
| Stage3-vs-Stage4 |
6.647400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.022100E-02 |
| Normal-vs-AfricanAmerican |
1.155930E-03 |
| Normal-vs-Asian |
1.435520E-02 |
| Caucasian-vs-AfricanAmerican |
6.602300E-02 |
| Caucasian-vs-Asian |
4.164800E-01 |
| AfricanAmerican-vs-Asian |
6.478800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.373400E-04 |
| Normal-vs-Female |
7.071400E-01 |
| Male-vs-Female |
1.723090E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.326140E-02 |
| Normal-vs-Extreme_Weight |
3.437400E-04 |
| Normal-vs-Obese |
4.063000E-01 |
| Normal-vs-Extreme_Obese |
1.013520E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.239600E-01 |
| Normal_Weight-vs-Obese |
1.171760E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.908400E-01 |
| Extreme_Weight-vs-Obese |
1.338420E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.856600E-01 |
| Obese-vs-Extreme_Obese |
1.915000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.449400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.841030E-01 |
| Normal-vs-Age(61-80Yrs) |
7.203900E-04 |
| Normal-vs-Age(81-100Yrs) |
4.416600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.459400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.074230E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.334400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.478500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.374190E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.674800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.255100E-03 |
| Normal-VS-Type2 PRCC |
5.437800E-03 |
| Normal-VS-KIRP CIMP |
5.769600E-01 |
| Normal-VS-Unclassified PRCC |
9.387200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.854600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.207900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.910200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.064500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.151600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.443000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.625900E-04 |
| Normal-vs-N1 |
9.098200E-01 |
| Normal-vs-N2 |
4.556400E-02 |
| N0-vs-N1 |
3.533700E-02 |
| N0-vs-N2 |
8.515400E-01 |
| N1-vs-N2 |
3.018800E-01 |
|
|
